1-198699632-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002838.5(PTPRC):​c.367G>C​(p.Asp123His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0158 in 1,614,164 control chromosomes in the GnomAD database, including 288 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 23 hom., cov: 32)
Exomes 𝑓: 0.016 ( 265 hom. )

Consequence

PTPRC
NM_002838.5 missense

Scores

2
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.27

Publications

15 publications found
Variant links:
Genes affected
PTPRC (HGNC:9666): (protein tyrosine phosphatase receptor type C) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitosis, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus is classified as a receptor type PTP. This PTP has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. This PTP also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. Alternatively spliced transcripts variants of this gene, which encode distinct isoforms, have been reported. [provided by RefSeq, Jun 2012]
PTPRC Gene-Disease associations (from GenCC):
  • immunodeficiency 104
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • T-B+ severe combined immunodeficiency due to CD45 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033371449).
BP6
Variant 1-198699632-G-C is Benign according to our data. Variant chr1-198699632-G-C is described in ClinVar as Benign. ClinVar VariationId is 138847.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0139 (2123/152278) while in subpopulation NFE AF = 0.0161 (1094/68010). AF 95% confidence interval is 0.0153. There are 23 homozygotes in GnomAd4. There are 1129 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTPRCNM_002838.5 linkc.367G>C p.Asp123His missense_variant Exon 5 of 33 ENST00000442510.8 NP_002829.3 P08575-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTPRCENST00000442510.8 linkc.367G>C p.Asp123His missense_variant Exon 5 of 33 1 NM_002838.5 ENSP00000411355.3 P08575-3

Frequencies

GnomAD3 genomes
AF:
0.0139
AC:
2111
AN:
152162
Hom.:
23
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00519
Gnomad AMI
AF:
0.00330
Gnomad AMR
AF:
0.0108
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0122
Gnomad FIN
AF:
0.0489
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0161
Gnomad OTH
AF:
0.0148
GnomAD2 exomes
AF:
0.0148
AC:
3714
AN:
251398
AF XY:
0.0152
show subpopulations
Gnomad AFR exome
AF:
0.00603
Gnomad AMR exome
AF:
0.00775
Gnomad ASJ exome
AF:
0.00526
Gnomad EAS exome
AF:
0.000217
Gnomad FIN exome
AF:
0.0487
Gnomad NFE exome
AF:
0.0156
Gnomad OTH exome
AF:
0.0130
GnomAD4 exome
AF:
0.0160
AC:
23408
AN:
1461886
Hom.:
265
Cov.:
31
AF XY:
0.0160
AC XY:
11602
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00499
AC:
167
AN:
33480
American (AMR)
AF:
0.00783
AC:
350
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00417
AC:
109
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0123
AC:
1065
AN:
86258
European-Finnish (FIN)
AF:
0.0474
AC:
2533
AN:
53420
Middle Eastern (MID)
AF:
0.0147
AC:
85
AN:
5766
European-Non Finnish (NFE)
AF:
0.0164
AC:
18238
AN:
1112006
Other (OTH)
AF:
0.0142
AC:
859
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
1447
2894
4340
5787
7234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
676
1352
2028
2704
3380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0139
AC:
2123
AN:
152278
Hom.:
23
Cov.:
32
AF XY:
0.0152
AC XY:
1129
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00544
AC:
226
AN:
41570
American (AMR)
AF:
0.0108
AC:
165
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00605
AC:
21
AN:
3472
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5174
South Asian (SAS)
AF:
0.0124
AC:
60
AN:
4824
European-Finnish (FIN)
AF:
0.0489
AC:
519
AN:
10606
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0161
AC:
1094
AN:
68010
Other (OTH)
AF:
0.0147
AC:
31
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
100
200
301
401
501
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0142
Hom.:
15
Bravo
AF:
0.0103
TwinsUK
AF:
0.0165
AC:
61
ALSPAC
AF:
0.0140
AC:
54
ESP6500AA
AF:
0.00658
AC:
29
ESP6500EA
AF:
0.0178
AC:
153
ExAC
AF:
0.0139
AC:
1684
Asia WGS
AF:
0.00779
AC:
28
AN:
3478
EpiCase
AF:
0.0167
EpiControl
AF:
0.0150

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Aug 02, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Immunodeficiency 104 Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.034
.;.;T;.;T
Eigen
Benign
0.079
Eigen_PC
Benign
-0.079
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.79
T;T;T;T;T
MetaRNN
Benign
0.0033
T;T;T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
1.3
PrimateAI
Benign
0.33
T
REVEL
Benign
0.070
Sift4G
Benign
0.11
.;T;T;.;D
Vest4
0.13
MPC
0.70
ClinPred
0.0088
T
GERP RS
3.3
Varity_R
0.10
gMVP
0.21
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41269905; hg19: chr1-198668761; COSMIC: COSV99049525; COSMIC: COSV99049525; API